Items where Author is "Ahmadzadeh, A."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.


Mortazavi-Jahromi, S. S. and Aslani, M. and Omidian, S. and Ahmadzadeh, A. and Rezaieyazdi, Z. and Mirshafiey, A. (2020) Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients. Drug Development Research, 81 (3). pp. 295-304.

Khadivi zand, F. and Shariati, M. and Sabeti Aghabozorgi, A. and Saberi, S. and Khatib Astaneh, H. and Ahmadzadeh, A. and Samie, Z. and Ansari, P. and Sadr-Nabavi, A. and Jafarzadeh-Esfehani, R. (2020) Intellectual disability; an example of not relying on karyotype or array comparative genomic hybridization alone. Meta Gene, 24.

Mortazavi-Jahromi, S. S. and Ahmadzadeh, A. and Rezaieyazdi, Z. and Aslani, M. and Omidian, S. and Mirshafiey, A. (2020) The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients. Immunopharmacology and Immunotoxicology, 42 (3). pp. 228-236.

Rezaieyazdi, Z. and Farooqi, A. and Soleymani-Salehabadi, H. and Ahmadzadeh, A. and Aslani, M. and Omidian, S. and Sadoughi, A. and Vahidi, Z. and Khodashahi, M. and Zamurrad, S. and Mortazavi-Jahromi, S. S. and Fallahzadeh, H. and Hosseini, M. and Aghazadeh, Z. and Ekhtiari, P. and Matsuo, H. and Rehm, B. H. A. and Cuzzocrea, S. and D’Aniello, A. and Mirshafiey, A. (2019) International multicenter randomized, placebo-controlled phase III clinical trial of β-d-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology, 27 (5). pp. 911-921.

Jamshidi, A. and Gharibdoost, F. and Vojdanian, M. and Soroosh, S. G. and Soroush, M. and Ahmadzadeh, A. and Nazarinia, M. A. and Mousavi, M. and Karimzadeh, H. and Shakibi, M. R. and Rezaieyazdi, Z. and Sahebari, M. and Hajiabbasi, A. and Ebrahimi, A. A. and Mahjourian, N. and Rashti, A. M. (2017) A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis. Arthritis Research and Therapy, 19 (1).

This list was generated on Mon Apr 12 22:21:16 2021 EDT.